CG
BIO icon

Cutler Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Cutler Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-400
Closed -$298K – 5415
2021
Q3 		$298K Buy
+400
New +$300K 0.02% 1104
2017
Q2 		– Sell
-35
Closed -$6K – 6381
2017
Q1 		$6K Sell
35
-2,674
-99% -$515K ﹤0.01% 4507
2016
Q4 		$493K Buy
2,709
+210
+8% +$35.8K 0.02% 699
2016
Q3 		$409K Buy
2,499
+2,470
+8,517% +$375K 0.03% 712
2016
Q2 		$4K Sell
29
-1,525
-98% -$218K ﹤0.01% 5078
2016
Q1 		$212K Buy
+1,554
New +$204K 0.02% 978

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return